Mantos, Welvie B.
HRN: 25-88-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2024
CEFUROXIME 1.5GM (VIAL)
09/19/2024
09/26/2024
IV
1.5g
Q8 ANST
Temp: 38; With Fever And Chills
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes